---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-016066"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-23T23:57:03.798520+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GRI Bio prices $5M public offering of shares and warrants; net proceeds ~$4.2M

## Summary
- Priced public offering of 1,388,888 units at $3.60 each (share or pre-funded warrant plus Series E-1, E-2, E-3 warrants).
- Gross proceeds ~$5.0M; net ~$4.2M after 7% agent fee and expenses; closing expected April 2, 2025.
- Warrants exercisable at $3.20; if fully cash-exercised, additional gross proceeds ~$13.3M.
- Net proceeds for working capital and product development; cash runway expected only through Q3 2025.
- H.C. Wainwright acting as placement agent; receives warrants for 97,222 shares at $4.50 per share.

## SEC filing metadata
- accession: 0001628280-25-016066
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000162828025016066/0001628280-25-016066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000162828025016066/val-20250401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-016066
- JSON: https://secwatch.observer/filing/0001628280-25-016066.json
- Plain text: https://secwatch.observer/filing/0001628280-25-016066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.